The Technical Analyst
Embecta Corp. [EMBC]
Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Embecta Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
-0.87% $10.31
America/New_York / 26 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 593.64 mill |
| EPS: | 0.960 |
| P/E: | 10.74 |
| Earnings Date: | May 09, 2024 |
| SharesOutstanding: | 57.58 mill |
| Avg Daily Volume: | 0.436 mill |
| RATING 2024-04-26 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Buy | |
| DE: | Strong Sell | |
| P/E: | Buy | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 10.74 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.22x |
| Company: PE 10.74 | industry: PE 47.78 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 9.79 - 10.83 ( +/- 5.08%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2022-04-01 | Reidy Christopher R | Sell | 0 | Common Stock |
| 2022-04-01 | Melcher David F | Sell | 0 | Common Stock |
| 2024-04-04 | Kurdikar Devdatt | Sell | 4 535 | Common Stock |
| 2024-02-11 | Kurdikar Devdatt | Sell | 17 165 | Common Stock |
| 2024-02-12 | Melcher David F | Buy | 2 000 | Common Stock |
| INSIDER POWER |
|---|
| 77.59 |
| Last 100 transactions |
| Buy: 2 135 787 | Sell: 79 609 |
Forecast:
16:00 - $10.31
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $10.31
Forecast 2: 16:00 - $10.31
Forecast 3: 16:00 - $10.31
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $10.31 (-0.87% ) |
| Volume | 0.251 mill |
| Avg. Vol. | 0.436 mill |
| % of Avg. Vol | 57.52 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For EMBC
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $17.74 | N/A | Active |
|---|
EMBC
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Latest Press Releases
2024-04-23 17:00:00 - Press Release
Embecta To Report Fiscal Second Quarter 2024 Financial Results
Parsippany, n.j., april 23, 2024 (globe newswire) -- embecta corp. (“embecta”) (nasdaq: embc), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2024 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. eastern time (et) on thursday, may 9, 2024.
2024-03-06 06:00:00 - Press Release
Embecta-sponsored Educational Symposium And Abstracts At Attd Highlight Role Of Insulin Pumps In The Management Of Type 2 Diabetes
Parsippany, n.j., march 06, 2024 (globe newswire) -- embecta corp. (“embecta”) (nasdaq: embc), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its sponsorship of a symposium at the advanced technologies & treatments for diabetes (attd) international conference.
2024-02-09 06:30:00 - Press Release
Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results
Parsippany, n.j., feb. 09, 2024 (globe newswire) -- embecta corp. (“embecta” or the "company") (nasdaq: embc), a global diabetes care company, today reported financial results for the three month period ended december 31, 2023.
2024-02-09 06:00:00 - Press Release
Embecta Announces Quarterly Cash Dividend
Parsippany, n.j., feb. 09, 2024 (globe newswire) -- the board of directors of embecta corp. (“embecta”) (nasdaq: embc) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the company's common stock. the dividend is payable on march 15, 2024 to stockholders of record at the close of business on february 28, 2024.
2024-02-07 17:00:00 - Press Release
Embecta To Participate In The 11th Annual Btig Medtech Conference
Parsippany, n.j., feb. 07, 2024 (globe newswire) -- embecta corp. (embecta) (nasdaq: embc) today announced that management will host one-on-one investor meetings on tuesday, february 13, 2024, at the cliff lodge, snowbird, ut.
Latest News
2024-04-23 17:00:00 - GlobeNewsWire
embecta to Report Fiscal Second Quarter 2024 Financial Results
PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2024 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, May 9, 2024.
2024-02-12 05:51:03 - Zacks Investment Research
Best Value Stocks to Buy for February 12th
XRX, EMBC and HMN made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 12, 2023.
2024-02-09 11:43:23 - The Motley Fool
Why Embecta Stock Is Tanking Today
Embecta beat Wall Street estimates with its fiscal 2024 Q1 revenue and earnings. The company's full-year outlook, though, came in below consensus estimates.
2024-02-09 08:46:03 - Zacks Investment Research
Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates
Embecta Corp. (EMBC) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.96 per share a year ago.
2024-01-24 17:00:00 - GlobeNewsWire
embecta to Report Fiscal First Quarter 2024 Financial Results
PARSIPPANY, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal first quarter 2024 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, February 9, 2024.
2023-12-20 15:47:04 - Zacks Investment Research
Time to Buy These Intriguing Additions to Zacks Rank #1 (Strong Buy) List
Several intriguing stocks were recently added to the Zacks Rank #1 (Strong Buy) list this week and shouldn't be overlooked as we round out what has been an exciting year for the stock market.
2023-11-29 17:00:00 - GlobeNewsWire
embecta to Participate in Investor Conferences
PARSIPPANY, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today announced that management will participate in the following investor events:
2023-11-21 08:16:05 - Zacks Investment Research
Embecta Corp. (EMBC) Beats Q4 Earnings and Revenue Estimates
Embecta Corp. (EMBC) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.73 per share a year ago.
2023-10-25 17:00:00 - GlobeNewsWire
embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results
PARSIPPANY, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, will host a conference call to discuss its fiscal fourth quarter and full year 2023 financial results, and provide an operational update, including preliminary fiscal year 2024 financial guidance, at 7:00 a.m. Eastern Time (ET) on Tuesday, November 21, 2023.
2023-10-17 20:30:00 - Seeking Alpha
Dividend Income Update September 2023
With the start of the final quarter of 2023, it's time to take a look back at my previous month of dividend income. Getting close to that $2,000 milestone in a month sure looks amazing. I know, those end of quarter months are always the big payers but it's still nice to see.